|
US4542020A
(en)
*
|
1984-08-17 |
1985-09-17 |
E. R. Squibb & Sons, Inc. |
Long-lasting adhesive antifungal suppositories
|
|
US4999342A
(en)
*
|
1988-08-16 |
1991-03-12 |
Ortho Pharmaceutical Corporation |
Long lasting contraceptive suppository composition and methods of use
|
|
GR1000603B
(el)
*
|
1989-08-16 |
1992-08-26 |
Ortho Pharma Corp |
Μακρας διαρκειας αντισυλληπτικη συνθεσις υποθετου και μεθοδοι χρησεως.
|
|
IT1251114B
(it)
*
|
1991-07-26 |
1995-05-04 |
Farcon Ag |
Forme farmaceutiche antivirali per applicazione vaginale
|
|
DE4400375C2
(de)
*
|
1994-01-08 |
1996-10-31 |
Schmittmann Hans Bernd |
Verwendung von erregerabtötend wirkenden Schäumen
|
|
FR2725371B1
(fr)
*
|
1994-10-05 |
1997-08-29 |
Techni Pharma |
Nouveau procede de fabrication de suppositoires
|
|
IT1275816B1
(it)
*
|
1995-10-27 |
1997-10-17 |
Montefarmaco Spa |
Composizioni farmaceutiche solide per uso vaginale
|
|
MA24525A1
(fr)
*
|
1997-04-14 |
1998-12-31 |
Procter & Gamble |
Particule detergente
|
|
EP0872544A1
(en)
*
|
1997-04-14 |
1998-10-21 |
The Procter & Gamble Company |
Dry effervescent granules and granular compositions comprising the same
|
|
US7135191B2
(en)
*
|
1997-09-04 |
2006-11-14 |
Zsolt Istvan Hertelendy |
Urogenital or anorectal transmucosal vaccine delivery system
|
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
US20030118645A1
(en)
*
|
1998-04-29 |
2003-06-26 |
Pather S. Indiran |
Pharmaceutical compositions for rectal and vaginal administration
|
|
US6576250B1
(en)
*
|
1998-03-27 |
2003-06-10 |
Cima Labs Inc. |
Pharmaceutical compositions for rectal and vaginal administration
|
|
US20030091629A1
(en)
*
|
1998-03-27 |
2003-05-15 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
|
US6350470B1
(en)
|
1998-04-29 |
2002-02-26 |
Cima Labs Inc. |
Effervescent drug delivery system for oral administration
|
|
US6974590B2
(en)
*
|
1998-03-27 |
2005-12-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
|
IL127129A
(en)
*
|
1998-11-18 |
2004-06-01 |
Ferring Bv |
Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
|
|
US20070178139A1
(en)
*
|
1998-11-18 |
2007-08-02 |
Yankov Vladimir I |
Vaginally administratable progesterone-containing tablets and method for preparing same
|
|
US6426111B1
(en)
|
2000-06-02 |
2002-07-30 |
Gerald Phillip Hirsch |
Effervescent mixtures and methods of making
|
|
US20040047910A1
(en)
*
|
2000-07-07 |
2004-03-11 |
Christian Beckett |
Suppository and composition comprising at least one polyethylene glycol
|
|
CA2345014C
(en)
*
|
2000-08-11 |
2010-04-20 |
Unilever Plc |
Packaged cosmetic effervescent cleansing pillow
|
|
EP1318790A4
(en)
*
|
2000-09-19 |
2006-02-01 |
Cima Labs Inc |
PHARMACEUTICAL COMPOSITIONS FOR RECTAL AND VAGINAL ADMINISTRATION
|
|
JP4346311B2
(ja)
*
|
2001-04-27 |
2009-10-21 |
京都薬品工業株式会社 |
発泡性坐剤の保存方法
|
|
GB0217056D0
(en)
*
|
2002-07-23 |
2002-08-28 |
Ass Octel |
Use
|
|
WO2005065317A2
(en)
|
2003-12-31 |
2005-07-21 |
Cima Labs Inc. |
Effervescent oral fentanyl dosage form
|
|
AU2004311879B2
(en)
*
|
2003-12-31 |
2010-08-05 |
Cima Labs Inc. |
Effervescent oral opiate dosage form
|
|
EP1708686B1
(en)
*
|
2003-12-31 |
2011-02-16 |
Cima Labs Inc. |
Generally linear effervescent oral fentanyl dosage form and methods of administering
|
|
BRPI0711525A2
(pt)
*
|
2006-06-02 |
2011-11-01 |
Pear Tree Women S Health Care |
composição farmacêutica e método para tratar sintomas de vaginite atrófica
|
|
EP1872807A1
(en)
*
|
2006-06-30 |
2008-01-02 |
Scil Technology GmbH |
Biomaterial containing degradation stabilized polymer
|
|
EP2046932A2
(en)
*
|
2006-08-03 |
2009-04-15 |
Ciba Holding Inc. |
Composition for improving wettability of surfaces
|
|
JP2010522135A
(ja)
|
2006-10-09 |
2010-07-01 |
チャールストン ラボラトリーズ，インコーポレイテッド |
医薬組成物
|
|
ES2467942T3
(es)
*
|
2007-09-20 |
2014-06-13 |
Lapidot Medical Import And Marketing Ltd |
Composiciones y medios para tratar leiomiomas uterinos, leiomioma, mioma, fibroides uterinos, endometriosis, adenomiosis y trastornos relacionados por mifepristona.
|
|
EP2240022B1
(en)
|
2008-01-09 |
2016-12-28 |
Charleston Laboratories, Inc. |
Bilayered tablets comprising oxycodone and promethazine
|
|
US20100087402A1
(en)
*
|
2008-09-29 |
2010-04-08 |
Vivus, Inc. |
Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders
|
|
EA021943B1
(ru)
*
|
2009-01-09 |
2015-10-30 |
Эгиш Дьёдьсердьяр Ньильваношан Мюкеде Ресвеньтаршашаг |
Способ изготовления вагинального суппозитория
|
|
CA2767576C
(en)
|
2009-07-08 |
2020-03-10 |
Charleston Laboratories Inc. |
Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
|
|
IT1403661B1
(it)
*
|
2011-01-28 |
2013-10-31 |
Probiotical Spa |
Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
|
|
ITMI20110791A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri in grado di metabolizzare gli ossalati.
|
|
ITMI20110793A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
|
|
ITMI20110792A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
|
|
ITRM20110477A1
(it)
|
2011-09-09 |
2013-03-10 |
Giovanni Mogna |
Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
|
|
ITMI20111718A1
(it)
|
2011-09-23 |
2013-03-24 |
Probiotical Spa |
Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
|
|
ITMI20130793A1
(it)
|
2013-05-14 |
2014-11-15 |
Probiotical Spa |
Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
|
|
WO2015129800A1
(ja)
*
|
2014-02-26 |
2015-09-03 |
セオリアファーマ株式会社 |
ジオクチルソジウムスルホサクシネート耳鼻科用液剤
|
|
JP2019507181A
(ja)
|
2016-03-04 |
2019-03-14 |
チャールストン ラボラトリーズ，インコーポレイテッド |
医薬組成物
|
|
US10966924B2
(en)
*
|
2018-09-04 |
2021-04-06 |
Babak Ghalili |
Veterinary cannabinoid, menthol and anesthetic compositions and methods
|